D74.0
Congenital methemoglobinemia
Clinical Classification Guidelines
Inclusion Terms
- Congenital NADH-methemoglobin reductase deficiency
- Hemoglobin-M [Hb-M] disease
- Methemoglobinemia, hereditary
Medical Intelligence & Overview
Congenital methemoglobinemia is a rare inherited condition where an abnormal form of hemoglobin, called methemoglobin, is present in the blood. Hemoglobin is the protein in red blood cells responsible for transporting oxygen from the lungs to the body's tissues. Normally, a small amount of methemoglobin is present, but in this condition, its levels are higher than normal, which can affect oxygen delivery. The condition is present from birth, making it a congenital disorder. It is classified under ICD-10 code D74.0 and includes different genetic variations such as NADH-methemoglobin reductase deficiency and Hemoglobin M disease.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting hemoglobin structure or red blood cell enzymes Inheriting mutations associated with NADH-methemoglobin reductase deficiency Presence of Hemoglobin M variants that are abnormal forms of hemoglobin Family history of similar conditions that lead to increased methemoglobin levels
Key Symptoms: Cyanosis (a bluish discoloration of the skin and mucous membranes) Shortness of breath or difficulty breathing Fatigue or weakness Headaches Dizziness or lightheadedness Rarely, seizures or loss of consciousness if oxygen delivery is severely affected
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves blood tests to measure the levels of methemoglobin in the blood. Blood smears under a microscope may reveal abnormal hemoglobin variants. Genetic testing can identify specific mutations associated with inherited forms of the condition. Clinicians may also assess oxygen saturation levels using pulse oximetry, which can be misleading in methemoglobinemia due to abnormal hemoglobin color, prompting further blood analysis with co-oximetry to accurately measure methemoglobin levels.
Treatment Protocols: Many individuals with congenital methemoglobinemia are asymptomatic and require no treatment. For those experiencing symptoms, treatment options may include: - Administration of methylene blue, a medication that helps convert methemoglobin back to normal hemoglobin, - Use of ascorbic acid (vitamin C), which can reduce methemoglobin levels, - Avoidance of certain drugs or chemicals that may increase methemoglobin production, - Regular monitoring of blood oxygen levels and methemoglobin percentages, - In severe cases, exchange transfusions or chronic treatment may be considered.
Clinical Advice & FAQs
Billing Guidance
Is D74.0 a billable ICD-10 code?
Yes, D74.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D74.0?
Clinical documentation must specify the nature of Congenital methemoglobinemia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference